Revision Pharmaceutical Group is a large modern private enterprise integrating scientific research, production and marketing. Its headquarters is in Changchun and its marketing headquarters is in Beijing. The industrial layout extends from Tonghua, a famous medical city, to Liuhe, Shuangyang, Changchun, Beijing, Sichuan, Nanchang and other places.
The total floor area is117000m2, and the total construction area is 390000m2. The Group has 66 wholly-owned subsidiaries with more than 80,000 employees and total assets of 7.5 billion yuan.
Xiu Laigui, the chairman, founded Xiu Laigui, 1995, is a large-scale modern private pharmaceutical enterprise integrating scientific research, production and marketing, chemical pharmacy and biopharmaceuticals, drug chain management and standard cultivation of Chinese herbal medicines. Revision Pharmaceutical has two head offices, three national famous trademarks of "Revision, Tanya and Starwood" and 14 sales platforms.
Extended data:
By the end of 20 16, the group had 27 subsidiaries/kloc-0, with more than 654.38+million employees and stock assets/kloc-0.7 billion yuan. It has 24 dosage forms and more than 2,000 varieties of medicines and health products, including 109 varieties.
More than 50 varieties have sold over 100 million, more than 20 varieties have exceeded 654.38+0 billion, and more than 50 varieties have development potential. Among them, through secondary development, more than a dozen large varieties, such as Ning Fei, Xiaomi Shuan, Liuwei Dihuang, Jingyaokang, Yiqi Yangxue, have been cultivated. Using new preparation technology, Starshu pellets and dispersible tablets were developed, which ensured the position of correction liquid in the domestic stomach medicine market.
It has a domestic scientific research system integrating scientific and technological management, innovative drug research and the transformation of new technological achievements. It has more than 300 technical experts from China, obtained more than 700 authorized patents and won 7 national scientific and technological progress awards.